2026
The Price at the Counter: What Corporate Pharma Deals Mean for the Family Medicine Box
When a massive investment firm partners with a national pharma procurer, the real test isn't the stock price—it’s the price at the pharmacy.
2026
When a massive investment firm partners with a national pharma procurer, the real test isn't the stock price—it’s the price at the pharmacy.
2026
P18 billion in investment pledges are coming to Aurora. But beyond the staggering numbers, what changes for the ordinary family at home?
2026
When global credit experts sound alarms about our banks, the real story isn't about corporate profits—it's about the cost of your groceries.
2026
When the country buys less food from abroad and sells more of its own, the numbers look great on paper. But what does it change at home?
2026
Paano natin ipagdiriwang ang Araw ng Kalayaan kung ang marami sa atin ay tila bihag pa rin ng mataas na bilihin at kawalan ng kasiguruhan?
2026
The global AI boom is knocking on the Philippines' door. But will it create better jobs for ordinary Filipinos, or leave them behind?
2026
When the country misses its economic targets, it isn't just a failure of statistics—it's a story of vulnerability for millions of homes.
2026
Plans for a multi-billion peso national oil reserve are underway. Here is what it actually means for your daily commute and household budget.
2026
Waking up to an empty bank account is every Filipino's worst digital nightmare. By June 25, 2026, new rules change how we fight back.
2026
When a corporate giant moves billions, the real story isn't on the stock exchange—it’s in the changing landscape of our local communities.
2026
When the government borrows 66% less in a single month, it sounds like abstract math. But it actually changes the rhythm of your daily budget.
2026
Factories are getting busier again, but workers are still losing jobs. Here is the real story behind the latest manufacturing report.